PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.\', \'Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; PET Centre, Centre for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden.\', \'Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.\', \'Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.\', \'GlaxoSmithKline, Clinical Imaging, UK.\', \'Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden; PET Centre, Centre for Medical Imaging, Uppsala University Hospital, Uppsala, Sweden. Electronic address: gunnar.antoni@akademiska.se.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0969-8051(22)00001-410.1016/j.nucmedbio.2022.01.001
?:hasPublicationType
?:journal
  • Nuclear medicine and biology
is ?:pmid of
?:pmid
?:pmid
  • 35066391
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.696
?:rankingScore_hIndex
  • 81
is ?:relation_isRelatedTo_publication of
?:title
  • Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase.
?:type

Metadata

Anon_0  
expand all